Sodium pyruvate ameliorates in vitro oxidative damage resulting from lethal methemoglobinemia

Ya Huang,Jiajun Du,Lian Zhao,Jingxiang Zhao,Guoxing You,Jing Yang,Zhen Wang,Fangqiang,Zhou,Ying Wang,Hong Zhou
2018-01-01
Abstract:Introduction: The goal of this study was to evaluate the effects of sodium pyruvate (SP) on lethal methemoglobinemia with rat RBCs in vitro. Methods: Eight mM H2O2 was added to Group H2O2 to induce a lethal methemoglobinemia model. Group SP was pretreated with SP (5, 10, 20, and 50 mM, respectively) to verify the effects of SP on the lethal methemoglobinemia. Variables regarding oxidative stress, energy metabolism and oxygen delivery were determined. Results: The increased levels of MetHb, ROS, and MDA, but decreased contents of ATP and GSH, activities of LDH and Na+-K+ATPase and levels of 2,3-DPG and P50 are shown in the methemoglobinemia model. Pretreatments with SP significantly reduced MDA generations, increased GSH and ATP levels and enhanced the activities of LDH and Na+-K+ATPase. SP also maintained RBC function via inhibiting transformation of Hb to metHb and increasing the 2,3-DPG level and the P50 value. Conclusion: SP ameliorated lethal methemoglobinemia in vitro, through promoting glycolytic pathways, thus enhancing redox potentials and function with rat RBCs. SP may be a prospective protective agent for lethal methemoglobinemia.
What problem does this paper attempt to address?